Alpha Teknova Inc
NASDAQ:TKNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alpha Teknova Inc
NASDAQ:TKNO
|
US |
Intrinsic Value
The intrinsic value of Alpha Teknova Inc (TKNO) under the Base Case is 3.77 USD per share.
Compared with the current market price of 7.42 USD, the stock appears
Overvalued by 49% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -42% last year to 15% by 2031. If operating margin stayed at its five-year average of -59%, the estimate would be about $2.12. The forecast years subtract value, so the estimate rests entirely on the years after 2031.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Alpha Teknova Does
Alpha Teknova makes ready-to-use consumables for life science labs, especially cell culture media, buffers, and other reagents used in research, drug development, and molecular testing. Its products are the basic ingredients scientists need to grow cells, run experiments, and prepare samples, so the company sits early in the biotech supply chain rather than selling finished medicines or instruments.
- Headquarters
- United States of America US
- Employees
- 158
- IPO date
- Jun 25, 2021
Earnings Waterfall
Alpha Teknova Inc
The intrinsic value for Alpha Teknova Inc (TKNO) under the Base Case is 3.77 USD.
Compared with the current market price of 7.42 USD, the stock appears Overvalued by 49% .